Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

HER2/neu test

A laboratory test that measures the amount of HER2/neu protein on cancer cells or how many copies of the HER2/neu gene are in the DNA of cancer cells. The HER2/neu protein helps control normal cell growth. Larger than normal amounts of the HER2/neu protein or too many copies of the HER2/neu gene may be made by some types of cancer, including breast, ovarian, bladder, pancreatic, and stomach cancers. This may cause cancer cells to grow more quickly and spread to other parts of the body. A HER2/neu test may be done to help plan treatment, which may include drugs that target the HER2/neu protein. It is a type of tumor marker test. Also called HER2 test and human epidermal growth factor receptor 2 test.
Search NCI's Dictionary of Cancer Terms